Increased levels of GPR132 promote the infiltration of protumoral MDMs into breast tumors, while the pharmacological inhibition and genetic deletion of GPR132 reduce tumor growth and metastasis [97, 98]. This evidence concerns the gene GPR132 and neoplasm.